AKTX AKTX

Akari Therapeutics Share Price

0.555
0.0148 (2.74%)
Upgrade to Real-Time
Regular Market
0.555
Volume 22,476
Bid Price 0.5415
Ask Price 0.555
News -
Company Name Stock Ticker Symbol Market Type
Akari Therapeutics PLC AKTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.0148 2.74% 0.555 09:58:44
Open Price Low Price High Price Close Price Prev Close
0.54 0.54 0.555 0.5402
Trades Volume VWAP Dollar Volume Avg Volume
19 22,476  0.5422581  12,188 -
Last Trade Time Type Quantity Stock Price Currency
09:58:44 3,000  0.555 USD

Period:

Draw Mode:

Akari Therapeutics PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 32.94M 59.35M 58.03M  -  - -0.42 -1.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News Akari Therapeutics

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

AKTX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. The firm earns majority of its revenues from United Kingdom. It operates mainly in United States and United Kingdom.